JP2008519808A - 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用 - Google Patents

膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用 Download PDF

Info

Publication number
JP2008519808A
JP2008519808A JP2007540652A JP2007540652A JP2008519808A JP 2008519808 A JP2008519808 A JP 2008519808A JP 2007540652 A JP2007540652 A JP 2007540652A JP 2007540652 A JP2007540652 A JP 2007540652A JP 2008519808 A JP2008519808 A JP 2008519808A
Authority
JP
Japan
Prior art keywords
compound
vitamin
methyl
mmol
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007540652A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519808A5 (https=
Inventor
アドリニ ルシアノ
ペンナ ギウセッペ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
Bioxell SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0424965A external-priority patent/GB0424965D0/en
Application filed by Bioxell SpA filed Critical Bioxell SpA
Publication of JP2008519808A publication Critical patent/JP2008519808A/ja
Publication of JP2008519808A5 publication Critical patent/JP2008519808A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007540652A 2004-11-12 2005-11-11 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用 Abandoned JP2008519808A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0424965A GB0424965D0 (en) 2004-11-12 2004-11-12 Novel method
US66840805P 2005-04-04 2005-04-04
PCT/EP2005/055931 WO2006051106A1 (en) 2004-11-12 2005-11-11 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer

Publications (2)

Publication Number Publication Date
JP2008519808A true JP2008519808A (ja) 2008-06-12
JP2008519808A5 JP2008519808A5 (https=) 2008-12-25

Family

ID=35520127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540652A Abandoned JP2008519808A (ja) 2004-11-12 2005-11-11 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用

Country Status (7)

Country Link
US (1) US20080293647A1 (https=)
EP (1) EP1812011A1 (https=)
JP (1) JP2008519808A (https=)
AU (1) AU2005303773A1 (https=)
CA (1) CA2586679A1 (https=)
IL (1) IL182812A0 (https=)
WO (1) WO2006051106A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013006230A2 (en) 2011-07-01 2013-01-10 Fox Chase Cancer Center Combined inhibition of the vitamin d receptor and dna replication in the treatment of cancer
US9889141B2 (en) 2014-10-14 2018-02-13 Institute For Cancer Research Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639596A (en) 1969-07-14 1972-02-01 Wisconsin Alumni Res Found Method of treating leg weakness in fowl with 25-hydroxycholecalciferol
US3739001A (en) 1971-10-22 1973-06-12 Wisconsin Alumni Res Found 25,26-dihydroxycholecalciferol
US3741996A (en) 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3715374A (en) 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3856780A (en) 1973-06-18 1974-12-24 T Narwid Synthesis of 25-hydroxycholesterol and derivatives thereof
US3847955A (en) 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
JPS5126859A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS5126858A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * s * hidorokishikorekarushifuerooruno seizoho
US3994878A (en) 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
JPS5271456A (en) 1975-12-12 1977-06-14 Chugai Pharmaceut Co Ltd Synthesis of 1alpha-hydroxysteroid derivatives
US4028349A (en) 1976-03-08 1977-06-07 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof
US4026882A (en) 1976-03-08 1977-05-31 Hoffmann-La Roche Inc. Syntheses of 3,24R,25- and 3,24S,25-trihydroxy-5,7-cholestadiene 24,25-ketals and alkanoyl derivatives thereof
US4021423A (en) 1976-03-08 1977-05-03 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholecalciferol
US4225525A (en) 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives
US4308264A (en) 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
US4502991A (en) 1983-08-18 1985-03-05 Wisconsin Alumni Research Foundation 23,23-Difluoro-1α,25-dihydroxy-vitamin D3
EP0197949A1 (en) 1984-10-04 1986-10-22 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
US4613594A (en) 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
CA1332841C (en) 1984-11-27 1994-11-01 Noboru Kubodera Vitamin d derivatives and process for producing the same
US5039671A (en) 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US4717721A (en) 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity
US4866048A (en) 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
US5247123A (en) 1987-09-14 1993-09-21 Hoffmann-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
US4898855A (en) 1987-09-14 1990-02-06 Hoffman-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
US5087619A (en) 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4847012A (en) 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US4927815A (en) 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
GB8904154D0 (en) 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB8915770D0 (en) 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5030772A (en) 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
EP0614455B1 (en) 1991-11-07 1996-02-21 Research Institute For Medicine And Chemistry Inc. Vitamin d amide derivatives
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
GB9214202D0 (en) 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
CA2096105A1 (en) 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
TW267161B (https=) 1992-11-20 1996-01-01 Hoffmann La Roche
US5547947A (en) 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5565589A (en) 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5428029A (en) 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
DE69507714D1 (de) 1994-11-21 1999-03-18 Wisconsin Alumni Res Found 18,19-dinor-vitamin-d-derivate
WO1996022973A1 (fr) 1995-01-23 1996-08-01 Chugai Seiyaku Kabushiki Kaisha Derives de vitamine d3 de 2-substitution
US5749845A (en) 1995-01-25 1998-05-12 Iotek, Inc. Delivering an agent to an organ
WO1996036340A1 (en) 1995-05-19 1996-11-21 Abbott Laboratories STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION
JP3372259B2 (ja) 1995-09-21 2003-01-27 ウィスコンシン・アルムニ・リサーチ・ファウンデーション カルシトリオール誘導体およびそれらの用途
US5747479A (en) 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
GB9607034D0 (en) 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
NO971934L (no) 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
SG70009A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
GB9622590D0 (en) 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
KR20050123185A (ko) 1996-12-20 2005-12-29 쥬가이 세이야쿠 가부시키가이샤 16-엔-비타민 ｄ 유도체
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6316642B1 (en) 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US5843928A (en) 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6030962A (en) 1997-04-28 2000-02-29 Synttex (U.S.A.) Inc. Vitamin D3 analogs with bis C-20 side chains
US5811414A (en) 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US5872113A (en) 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
AU7497798A (en) 1997-05-16 1998-12-08 F. Hoffmann-La Roche Ag 3-epi compounds of vitamin d3 and uses thereof
CA2289209C (en) 1997-05-16 2006-07-25 Women & Infants Hospital Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof
DE69834109T2 (de) 1997-05-16 2007-04-19 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
JPH1112175A (ja) * 1997-06-27 1999-01-19 Nisshin Flour Milling Co Ltd 白血病治療剤
US5939406A (en) 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
WO1999012894A1 (en) 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
AU9095398A (en) 1997-09-19 1999-04-12 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives and process for producing the same
GB9721156D0 (en) 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
DE69939106D1 (de) 1998-02-24 2008-08-28 Chugai Pharmaceutical Co Ltd Verfahren zur Herstellung von ED-71
AU3167699A (en) 1998-04-10 1999-11-01 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives substituted at the 2beta-position
US5962707A (en) 1998-08-18 1999-10-05 Wisconsin Alumni Research Foundation 19-nor-vitamin D3 compounds with calcemic activity
WO2000061776A1 (en) 1999-04-14 2000-10-19 Mercian Corporation Vitamin d derivatives and process for producing the same
AU3841900A (en) 1999-04-23 2000-11-10 Chugai Seiyaku Kabushiki Kaisha 3-methylated vitamin d derivatives
US6331642B1 (en) 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
US6051567A (en) 1999-08-02 2000-04-18 Abbott Laboratories Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
WO2001030751A2 (en) 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20020045606A1 (en) 1999-12-02 2002-04-18 Reddy Satyanarayana G. Esters of vitamin D3 and uses thereof
AU2001228330A1 (en) 2000-01-31 2001-08-14 Leo Pharma A/S Vitamin d-derivatives and their use in treating osteoporosis and related bone disorders
US7074777B2 (en) 2000-04-19 2006-07-11 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
NZ522909A (en) 2000-05-31 2004-09-24 Wisconsin Alumni Res Found 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
MXPA03000406A (es) 2000-07-14 2003-06-06 Wisconsin Alumni Res Found Uso de 2-metilen-19-nor-20(s)-1 alfa,25-dihidroxivitamina d3 para incrementar la resistencia de los huesos.
WO2002014268A1 (fr) 2000-08-14 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Derive de 1-methyl-20-epivitamine d
WO2002066424A1 (en) 2001-02-23 2002-08-29 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivative having substituent in 2-position
US6683219B2 (en) 2001-07-30 2004-01-27 Wisconsin Alumni Research Foundation Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
US7491711B2 (en) 2001-09-21 2009-02-17 Roche Palo Alto Llc Methods of treatment using 3-desoxy vitamin D3 analogs
US6559138B1 (en) 2001-09-21 2003-05-06 Syntex (U.S.A.) Llc 3-Desoxy-vitamin D3 analog esters
CA2459789A1 (en) 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
HK1079766B (zh) 2002-03-29 2007-05-25 威斯康星校友研究基金会 合成1α-羟基-2-亚甲基-19-去甲-高孕钙化醇的方法
US6846811B2 (en) 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
JP2004026811A (ja) 2002-04-30 2004-01-29 Kiyoshi Hashizume ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
WO2004067504A1 (ja) 2003-01-31 2004-08-12 Chugai Seiyaku Kabushiki Kaisha ２位置換ビタミンｄ誘導体
JP2007506780A (ja) 2003-09-24 2007-03-22 ビオエクセル エスピーエー 膀胱機能障害の治療方法
AU2005228447A1 (en) * 2004-03-29 2005-10-13 Roswell Park Cancer Institute Method of treating solid tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs

Also Published As

Publication number Publication date
CA2586679A1 (en) 2006-05-18
IL182812A0 (en) 2007-09-20
WO2006051106A1 (en) 2006-05-18
US20080293647A1 (en) 2008-11-27
EP1812011A1 (en) 2007-08-01
AU2005303773A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
JP2002505668A (ja) 環状エーテルビタミンＤ３化合物、１α（ＯＨ）３−エピ−ビタミンＤ３化合物及びそれらの使用法
KR20030032015A (ko) 1α-히드록시-2-메틸렌-19-노르-호모프레그나칼시페롤 및그의 치료적 용도
JP2005510536A (ja) 活性ビタミンｄ類縁物質を使用した過剰増殖性疾病の治療
CN101141966A (zh) 维生素d化合物在治疗子宫内膜异位症中的应用
KR20040015301A (ko) 활성 비타민 ｄ 동족체를 사용하여 악성 종양으로 인한고칼슘혈증을 치료하는 방법
JP2007525533A (ja) 間質性膀胱炎の治療方法、並びに関連化合物及び組成物
JP2007530421A (ja) （２０Ｓ）−１α−ヒドロキシ−２−メチレン−１９−ノル−ビタミンＤ３及びその使用
JP2007506780A (ja) 膀胱機能障害の治療方法
JP2008519808A (ja) 膀胱癌治療のためのビタミンｄ誘導体及び抗増殖薬の併用
US20080280860A1 (en) Use of Vitamin D Compounds to Treat Endometriosis
JP4512490B2 (ja) ビタミンｄ類似体、該類似体を含んで成る組成物およびその使用
JP2021167319A (ja) カルシトリオールの２−メチレン類似体および関連化合物の合成および生物活性
CN1953752A (zh) 用维生素d化合物治疗间质性膀胱炎
JP2007506736A (ja) ヒトの平均余命を増加するための２−メチレン−１９−ノル−２０（Ｓ）−１α，２５−ヒドロキシビタミンＤ３の使用
WO2006035075A1 (en) Use of vitamin d compounds for the prevention or treatment of chronic prostatitis
CN101522199A (zh) 治疗男性低生育力的新方法
JP2006526662A (ja) 過増殖性細胞疾患を治療する方法
JP2010505921A (ja) 男性受精能低下の新規治療法
US20100009949A1 (en) Novel method
JP2010504306A (ja) 新規方法
CN101541330A (zh) 维生素d化合物用于预防粘连的用途
ZA200602097B (en) Methods for treating bladder dysfunction

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081110

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20100210